Corteva Narrows Q3 Loss, YTD Profit Surges on Strong Sales

Ticker: CTVA · Form: 10-Q · Filed: 2025-11-05T00:00:00.000Z

Sentiment: bullish

Topics: Agriculture, Crop Protection, Seed Technology, Earnings Report, Inflation Risk, Debt Management, Global Markets

Related Tickers: CTVA, DE, AGCO

TL;DR

**CTVA's Q3 loss narrowed, but the year-to-date profit jump and debt reduction make it a strong buy for long-term agricultural growth.**

AI Summary

Corteva, Inc. reported a net loss of $318 million for the three months ended September 30, 2025, a significant improvement from the $521 million net loss in the same period of 2024. Despite this quarterly loss, the company achieved a net income of $1,654 million for the nine months ended September 30, 2025, up from $958 million in the prior year. Net sales increased to $2,618 million for the quarter, compared to $2,326 million in Q3 2024, and reached $13,491 million year-to-date, an increase from $12,930 million. Key business changes include a reduction in short-term borrowings from $3,741 million in September 2024 to $2,685 million in September 2025, and a decrease in inventories from $5,674 million to $5,310 million. Risks include exposure to the highly-inflationary Argentine economy, where a 10% deterioration in the Peso to USD exchange rate could still impact net monetary assets. The strategic outlook involves managing this exposure through foreign government bonds, with $98 million held as of September 30, 2025.

Why It Matters

Corteva's improved financial performance, particularly the narrowed Q3 loss and substantial year-to-date net income growth, signals a stronger operational footing for investors. The reduction in short-term debt and inventory levels suggests more efficient capital management and potentially better cash flow, which could free up resources for strategic investments or shareholder returns. For employees, a healthier company often means greater job security and potential for growth. Customers benefit from a stable supplier in the agricultural sector, ensuring continued access to essential seeds and crop protection products. In the broader market, Corteva's performance reflects trends in the global agriculture industry, and its ability to navigate economic challenges like the Argentine inflation provides competitive insights for peers.

Risk Assessment

Risk Level: medium — The company faces a medium risk level primarily due to its exposure to the highly-inflationary Argentine economy, which contributes approximately 3% to annual net sales and less than 2% to segment operating EBITDA. While Corteva holds $98 million in foreign government bonds to manage this exposure, a further 10% deterioration in the Peso to USD exchange rate could still impact net monetary assets and pre-tax earnings, as noted in Note 1.

Analyst Insight

Investors should consider Corteva's improved year-to-date profitability and reduced short-term debt as positive indicators. Monitor the company's strategies for managing its Argentine exposure, specifically the performance of the $98 million in foreign government bonds, as this remains a notable, albeit managed, risk factor.

Financial Highlights

revenue
$13,491M
net Income
$1,654M
eps
$2.41
revenue Growth
+4.34%

Revenue Breakdown

SegmentRevenueGrowth
Total Net Sales$2,618M+12.56%
Total Net Sales (YTD)$13,491M+4.34%

Key Numbers

Key Players & Entities

FAQ

What were Corteva's net sales for the third quarter of 2025?

Corteva, Inc. reported net sales of $2,618 million for the three months ended September 30, 2025, an increase from $2,326 million in the same period of 2024.

How did Corteva's net income change year-to-date in 2025 compared to 2024?

For the nine months ended September 30, 2025, Corteva's net income was $1,654 million, a substantial increase from $958 million reported for the same period in 2024.

What was Corteva's basic earnings per share from continuing operations for Q3 2025?

Corteva's basic earnings per share from continuing operations for the three months ended September 30, 2025, was a loss of $0.46, an improvement from a loss of $0.76 in Q3 2024.

What is the functional currency for Corteva's Argentine subsidiaries?

Since 2018, the U.S. Dollar (USD) has been the functional currency for Corteva's Argentine subsidiaries due to Argentina being considered a highly-inflationary economy under U.S. GAAP.

How much in foreign government bonds does Corteva hold to manage its Argentina exposure?

As of September 30, 2025, Corteva holds foreign government bonds with an amortized cost of $98 million as part of its strategy to manage its net monetary asset exposure in Argentina.

What was the total equity attributable to Corteva stockholders as of September 30, 2025?

Total Corteva stockholders' equity stood at $25,219 million as of September 30, 2025, up from $24,737 million as of September 30, 2024.

How many shares of common stock did Corteva have outstanding on October 29, 2025?

Corteva, Inc. had 675,732,000 shares of common stock, par value $0.01 per share, outstanding at October 29, 2025.

What was Corteva's total cash provided by (used for) operating activities for the nine months ended September 30, 2025?

Corteva used $969 million in cash for operating activities for the nine months ended September 30, 2025, an improvement from using $2,028 million in the same period of 2024.

What is the impact of a 10% Peso devaluation on Corteva's pre-tax earnings?

As of September 30, 2025, a further 10% deterioration in the official Peso to USD exchange rate would not have a significant impact on the USD value of Corteva's net monetary assets or pre-tax earnings.

What was Corteva's short-term borrowings and finance lease obligations as of September 30, 2025?

Corteva's short-term borrowings and finance lease obligations were $2,685 million as of September 30, 2025, a decrease from $3,741 million as of September 30, 2024.

Risk Factors

Industry Context

Corteva operates in the agricultural sciences sector, providing seeds, crop protection, and digital solutions. The industry is characterized by consolidation, innovation in biotechnology and digital farming, and sensitivity to global commodity prices and weather patterns. Competition comes from large multinational corporations and smaller specialized firms.

Regulatory Implications

As a global agricultural company, Corteva faces significant regulatory oversight concerning product safety, environmental impact, and intellectual property. Changes in regulations related to genetically modified organisms (GMOs), pesticide use, and data privacy for digital agriculture tools can impact market access and operational costs.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]

Key Dates

Glossary

Net sales
The total revenue generated from the sale of goods and services after deducting returns, allowances, and discounts. (Key indicator of top-line performance and market demand for Corteva's products.)
Net income (loss)
The profit or loss remaining after all expenses, including taxes and interest, have been deducted from revenue. (Measures the company's overall profitability.)
Diluted earnings (loss) per share
The net income or loss per share after accounting for all dilutive potential common shares, such as stock options and convertible securities. (Provides a per-share measure of profitability that accounts for potential dilution.)
Other comprehensive income (loss)
Unrealized gains or losses on certain investments and foreign currency translations that are not included in net income. (Reflects changes in equity from transactions not yet realized in the income statement.)
Cumulative translation adjustments
Gains or losses arising from the translation of the financial statements of foreign operations into the reporting currency. (Impacts comprehensive income due to foreign currency fluctuations, particularly relevant given international operations.)

Year-Over-Year Comparison

Corteva has demonstrated a strong recovery in profitability, with a reduced net loss of $318 million in Q3 2025 compared to $521 million in Q3 2024, and a substantial increase in year-to-date net income to $1,654 million from $958 million. Revenue has seen modest growth, with Q3 sales up 12.56% to $2,618 million and YTD sales up 4.34% to $13,491 million. Key balance sheet improvements include a significant reduction in short-term borrowings and a decrease in inventory levels, indicating enhanced financial discipline and operational efficiency.

Filing Stats: 4,784 words · 19 min read · ~16 pages · Grade level 14.6 · Accepted 2025-11-05 17:13:54

Key Financial Figures

Filing Documents

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 43 Cautionary Statements About Forward-Looking Statements 43 Recent Developments 44 Overview 44 Results of Operations 45 Recent Accounting Pronouncements 49 Segment Reviews 49 Non-GAAP Financial Measures 52 Liquidity & Capital Resources 54 Contractual Obligations 57 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 57 Item 4.

Controls and Procedures

Controls and Procedures 58 Part II Other Information Item 1.

Legal Proceedings

Legal Proceedings 60 Item 1A.

Risk Factors

Risk Factors 62 Item 2 . Unregistered Sales of Equity Securities and Use of Proceeds 63 Item 3 . Defaults Upon Senior Securities 64 Item 5. Other Information 64 Item 6. Exhibits 65 Exhibit Index 65 Signature 66 Consolidated Financial Statements of EIDP, Inc. (Unaudited) 67 1 Table of Contents Explanatory Note Corteva, Inc. owns all of the common equity interests in EIDP, Inc. EIDP, Inc. is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Securities Exchange Act of 1934, as amended. Unless otherwise indicated or the context otherwise requires, references in this Quarterly Report on Form 10-Q to: "Corteva" or "the company" refers to Corteva, Inc. and its consolidated subsidiaries (including EIDP); "EIDP" refers to EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company) and its consolidated subsidiaries or EIDP excluding its consolidated subsidiaries, as the context may indicate; "DowDuPont" refers to DowDuPont Inc. and its subsidiaries prior to the Corteva Separation (defined below); "Historical Dow" refers to The Dow Chemical Company and its consolidated subsidiaries prior to the Internal Reorganization (defined below); "Historical DuPont" refers to EIDP prior to the Internal Reorganization (defined below); "Internal Reorganizations" refers to the series of internal reorganization and realignment steps undertaken by Historical DuPont and Historical Dow to realign its business into three subgroups: agriculture, materials science and specialty products. Refer to the company's Annual Report on Form 10-K for the year ended December 31, 2024 for further information. "Dow Distribution" refers to the separation of DowDuPont's materials science business into a separate and independent public company on April 1, 2019 by way of a distribution of Dow Inc. through a pro rata dividend in-kind of all of the then-issued and outstanding shares of Dow Inc.'s common stock;

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

CONSOLIDATED FINANCIAL STATEMENTS

Item 1. CONSOLIDATED FINANCIAL STATEMENTS Corteva, Inc. Consolidated Statements of Operations (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, (In millions, except per share amounts) 2025 2024 2025 2024 Net sales $ 2,618 $ 2,326 $ 13,491 $ 12,930 Cost of goods sold 1,644 1,565 6,918 7,033 Research and development expense 351 348 1,061 1,037 Selling, general and administrative expenses 725 671 2,632 2,461 Amortization of intangibles 162 170 485 521 Restructuring and asset related charges - net 30 32 131 199 Separation costs 7 — 7 — Other income (expense) - net ( 23 ) ( 107 ) 95 ( 319 ) Interest expense 46 66 134 173 Income (loss) from continuing operations before income taxes ( 370 ) ( 633 ) 2,218 1,187 Provision for (benefit from) income taxes on continuing operations ( 62 ) ( 114 ) 477 274 Income (loss) from continuing operations after income taxes ( 308 ) ( 519 ) 1,741 913 Income (loss) from discontinued operations after income taxes ( 10 ) ( 2 ) ( 87 ) 45 Net income (loss) ( 318 ) ( 521 ) 1,654 958 Net income (loss) attributable to noncontrolling interests 2 3 8 10 Net income (loss) attributable to Corteva $ ( 320 ) $ ( 524 ) $ 1,646 $ 948 Basic earnings (loss) per share of common stock: Basic earnings (loss) per share of common stock from continuing operations $ ( 0.46 ) $ ( 0.76 ) $ 2.54 $ 1.30 Basic earnings (loss) per share of common stock from discontinued operations ( 0.01 ) — ( 0.13 ) 0.06 Basic earnings (loss) per share of common stock $ ( 0.47 ) $ ( 0.76 ) $ 2.41 $ 1.36 Diluted earnings (loss) per share of common stock: Diluted earnings (loss) per share of common stock from continuing operations $ ( 0.46 ) $ ( 0.76 ) $ 2.54 $ 1.29 Diluted earnings (loss) per share of common stock from discontinued operations ( 0.01 ) — ( 0.13 ) 0.06 Diluted earnings (loss) per share of common stock $ ( 0.47 ) $ ( 0.76 ) $ 2.41 $ 1.35 See Notes to the Interim Consolidated Financial Statements beginning on page 9.

View on Read The Filing